We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: -0.05 (-1.52%)
Spread: 0.10 (3.125%)
Open: 3.30
High: 3.30
Low: 3.25
Prev. Close: 3.30
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: IS Solutions, Netservices, Plant Health Care...

Mon, 14th Sep 2009 09:51

Higher revenues helped software services group IS Solutions post broadly unchanged profits in the six months to June 30.Pre-tax profits for the period totalled £184,000, compared with £189,000 the previous year, as revenues soared to £5.12m from £3.64m. During the year, the company completed the purchase of headquarters on Sunbury on Thames and invested in establishing a branch office in the Indian sub-continent.Business communications group Netservices expects to post an operating loss of about £200,000 for the year to August 31 due to time it will take to develop relationships with clients.Depressed agricultural markets resulted in widening losses at natural plant supplement supplier Plant Health Care (PHC). Revenue in the six months to June 30 fell to $5.5m from $7.8m over the same period the previous year and pre-tax losses grew to $3.9m from $3.3m. PHC said that it had received large orders from the seed giant Monsanto for its Harpin seed treatment.China Wonder reported a drop in half year profits despite a 21% rise in sales revenue and said it continues to actively seek expansion opportunities both in the People's Republic of China and the United Kingdom. Pre-tax profit fell to £220,053 in the six month ended 30 June from £253,546 last time. Sales revenue for the period was £2.11m when compared to the £1,743,863 of sales for the same period in 2008.Expansion into Brazil and Germany helped Publishing Technologies, which provides online systems and management software to academic publishers, narrow losses sharply in the six months to June 30. Pre-tax losses totalled £99,000 for the period, compared with £299,000 for the same period the previous year. Revenue climbed to £7.7m from £7.3m.Environmental Recycling cut net losses from £1.8m to £0.54m in the half-year to June, on sales up to £427,000 (£179,000). The increasing recycling agenda has led to a considerable number of enquiries and negotiations in respect of the application of the PIM Process in various sectors, it said. The one major difficulty that remains is the ongoing litigation with the group's former CEO in Kyrgyzstan, it added.Intelligent Environments has signed a three year rolling contract with Home Retail priced on IE's transactional revenue model. IE will deliver a comprehensive electronic card statement system for Argos and Homebase store card customers.Biotech ValiRx has created a new wholly owned trading subsidiary, ValiMedix, to distribute a range of new diagnostic screening products acquired from Pasante Healthcare. The new diagnostic screening products principally comprise the Self Check screening products which allow an individual to check for potential health problems at an early stage. International Brand Licensing slipped into losses in the half year to June, losing £170,000 against a profit of £248,000. IBL said the figures should be considered against the backdrop of a very depressed sporting goods industry and a big exceptional gain last time. Timestrip, which makes labels indicating how long containers for food have been unsealed, saw higher revenues and reduced losses in the six months to June 30.. Revenues in the six months to June 30 climbed to £386m from £268m as losses narrowed to £453m from £697m.The firm also reported positive feedback from NHS trials of its TimeStripPlus technology which is used to show if a temperature sensitive product such as a drug has been exposed to incorrect temperatures.Angel Mining lost £1.5m in the 12 months ended 28 February versus £4.2m in 2008 following the reversal of impairment provisions of £3.2m linked to exploration costs at Black Angel in Greenland.The company, formerly known as Angus & Ross, wants to get Nalunaq in the south of Greenland into production this year then try and get the Black Angel mine producing by the end of 2010.Titanium Resources tumbled on Monday as it said sales fell to $19.8m in the six months ended 30 June from $32.5m previously, although some of that was due to the sale of a Bauxite mine last year.The loss after tax narrowed to $4.95m from $20.2m a year earlier as the cost of sales fell by 52% to $20.7m. 'We believe the company is on track to achieve operating profitability for H2 2009,' said boss John Sisay.Superconductor energy technology firm Zenergy Power has reported a big drop in revenue for the first half of 2009 to €0.2m from €1m and an increase in losses to £5m from £2.6m before.But it says continuing growth in its order backlog, €2.3m at the end of June, will 'smooth' its revenue recognition over reporting periods. 'However, in the short-term we expect lumpiness to be a feature of our revenue generation and this is certainly the case with our 2009 reporting.'Mobile marketing and advertising group Velti grew pre-tax profit to €2.7m in the six months to 30 June, up from €1.6m in 2008 on revenue 36% higher to €21.7m.'During the remainder of 2009 we will continue to build up momentum and grow the Company in a sustainable way with a strong focus on cash flow,' said chief executive Alex Moukas.Online retailer of ethical fashion and lifestyle products Adili saw pre-tax losses widen in the year to 30 April 2009 from £1.59m to £1.90m on sales that rose from £0.35m to £0.55m. Sales for the first five months of the current financial year are up 29% on a year earlier.The first half of 2009 saw loss before tax widen at biopharmaceutical contract manufacturer Angel Biotechnology to £0.52m from £0.46m, but revenue improved to £0.6m from £0.48m. 'Due to the structure of contracts we currently have, revenue recognition is necessarily delayed resulting in lower figures for H1 [first half] 2009 than might have been expected with the value of business signed. This situation is expected to be rectified in H2 [second half] 2009 and into 2010 as the revenues from these projects are recognised,' the company said.Security and fire alarm firm Westminster Group has won a tolling 12-month contract to provide 24-hour bodyguard protection to a rich individual and his family in the Middle East. The contract is worth £0.54m.
More News
30 Jun 2022 11:35

AIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
23 Jun 2022 16:02

UK shareholder meetings calendar - next 7 days

Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
Wednesday 29 June 
Africa Opportunity Fund LtdAGM
Argo Blockchain PLCAGM
Atome Energy PLCAGM
Brave Bison Group PLCAGM
Concurrent Technologies PLCAGM
Eden Research PLCAGM
Facilities by ADF PLCAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Hurricane Energy PLCAGM
i(x) Net Zero PLCAGM
Lords Group Trading PLCAGM
MaxCyte IncAGM
Meggitt PLCAGM
Mobile Tornado Group PLCAGM
NB Distressed Debt Investment Fund LtdAGM
NetScientific PLCAGM
Provident Financial PLCAGM
RA International Group PLCAGM
Reabold Resources PLCAGM
Symphony Environmental Technologies PLCAGM
Team17 Group PLCAGM
ThinkSmart LtdGM re approval for capital return
Trinity Exploration & Production PLCAGM
URA Holdings PLCAGM
XP Factory PLCAGM
Zaim Credit Systems PLCAGM
Thursday 30 June 
3i Group PLCAGM
Ashtead Technology Holdings PLCAGM
Borders & Southern Petroleum PLCAGM
Caspian Sunrise PLCAGM
Cobra Resources PLCAGM
Crimson Tide PLCAGM
ECSC Group PLCAGM
Evraz PLCAGM
Gresham House Energy Storage Fund PLCAGM
GRIT Investment Trust PLCAGM
Gulf Marine Services PLCAGM
Hamak Gold LtdAGM
Hemogenyx Pharmaceuticals PLCAGM
Immotion Group PLCAGM
Inspiration Healthcare Group PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kropz PLCAGM
Likewise Group PLCAGM
Live Co Group PLCAGM
Location Sciences Group PLCAGM
LoopUp Group PLCAGM
M&C Saatchi PLCAGM
Microsaic Systems PLCAGM
Nostra Terra Oil & Gas CoAGM
Pathfinder Minerals PLCAGM
Playtech PLCAGM
Primorus Investments PLCAGM
Rockfire Resources PLCAGM
Roquefort Therapeutics PLCAGM
Sanne Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
Supply@ME Capital PLCAGM
Surface Transforms PLCAGM
Synairgen PLCAGM
Tower Resources PLCAGM
Trainline PLCAGM
ValiRx PLCAGM
Victoria Oil & Gas PLCAGM
Watchstone Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
17 Jun 2022 13:55

ValiRx expecting to grant extension of exclusivity to TheoremRx

(Sharecast News) - Cancer therapeutics and women's health-focussed ValiRx updated the market on its proposed sub-licensing agreement with TheoremRx for 'VAL201' on Friday.

Read more
17 Jun 2022 10:46

AIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
17 Jun 2022 10:41

ValiRx shares drop as cancer drug sub-licensing progress stalls

(Alliance News) - ValiRx PLC on Friday said it is expecting to be asked to extend the exclusivity period between itself and TheroemRx Inc regarding the proposed sub-licence of cancer treatment VAL201.

Read more
7 Jun 2022 19:03

IN BRIEF: ValiRx widens annual loss as R&D costs climb

ValiRx PLC - Nuneaton, England-based drug development company - Widens pretax loss in 2021 to GBP1.7 million from GBP1.5 million the previous year. Research and development costs rise 32% to GBP303,789 in the year from GBP230,115 a year prior. Total assets at December 31 fall to GBP3.5 million from GBP4.9 million at the end of 2020. Chief Executive Suzanne Dilly says the work completed during 2021 has provided a "strong foundation" for the company moving forward.

Read more
23 Mar 2022 20:53

TRADING UPDATES: Arecor Therapeutics wins patent approval in US

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2022 17:18

TRADING UPDATES: Amigo heads to vote; UniVision court date pushed back

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Mar 2022 10:53

AIM WINNERS & LOSERS: Eco Animal expects earnings below consensus

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2022 22:19

TRADING UPDATES: BioPharma backs Collegium; Eurasia creates Kola

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:

Read more
5 Jan 2022 10:50

AIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi

AIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi

Read more
5 Jan 2022 09:21

ValiRx enters agreement and potential sub-license with TheoremRx

ValiRx enters agreement and potential sub-license with TheoremRx

Read more
20 Dec 2021 15:00

TRADING UPDATES: InnovaDerma sees profit return; ValiRx amends licence

TRADING UPDATES: InnovaDerma sees profit return; ValiRx amends licence

Read more
20 Dec 2021 12:17

ValiRx amends longstanding licence deal with Cancer Research Technology

(Sharecast News) - Cancer therapeutics developer ValiRx announced on Monday that it has amended and restated the licence for the VAL201 peptide held by the company from Cancer Research Technology (CRT) to enable a range of sub-licensing options.

Read more
2 Nov 2021 14:34

TRADING UPDATES: Custodian sells car showroom; Samarkand buys Napiers

TRADING UPDATES: Custodian sells car showroom; Samarkand buys Napiers

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.